130 filings
Page 4 of 7
8-K
cvd7n0g
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
DEFM14A
3k77dpx4kxcmpx3
7 Oct 22
Proxy related to merger
5:10pm
PREM14A
2ke dje1ks8jt0qp
23 Sep 22
Preliminary proxy related to merger
5:04pm
DEFA14A
fepy4jsh
7 Sep 22
Additional proxy soliciting materials
6:52am
8-K
zjx 5gkkyay
7 Sep 22
Entry into a Material Definitive Agreement
6:49am
8-K
15ujz 52sp5q8
29 Jul 22
Entry into a Material Definitive Agreement
4:12pm
8-K
uz6n o03gi
3 Jun 22
Submission of Matters to a Vote of Security Holders
4:51pm
DEFA14A
1rqzmzzi4wneeh3a pqs
22 Apr 22
Additional proxy soliciting materials
6:22am
8-K
vtulob
14 Apr 22
Cost Associated with Exit or Disposal Activities
5:00pm
424B5
s8ke9
15 Mar 22
Prospectus supplement for primary offering
4:45pm
S-8
3wju08gpr7v8wj0e
15 Mar 22
Registration of securities for employees
7:35am
8-K
5qte45r
15 Mar 22
Imara Reports Full Year 2021 Financial Results and Business Highlights
7:07am
8-K
7gjn8e2 7s5
9 Nov 21
Imara Reports Third Quarter 2021 Financial Results and Business Highlights
7:13am
8-K
eh9oq
25 Oct 21
Departure of Directors or Certain Officers
5:12pm
S-8
qpgrz yewdve2hj1o
6 Aug 21
Registration of securities for employees
8:01am